Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: Implications for the pathogenesis of invasive aspergillosis

Journal of Leukocyte Biology

Volumn 82, Issue 4, 2007, Pages 839-848

  Orciuolo, Enrico ^a   Stanzani, Marta ^b   Canestraro, Martina ^a   Galimberti, Sara ^a   Carulli, Giovanni ^a   Lewis, Russell ^c   Petrini, Mario ^a   Komanduri, Krishna V ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Immune response; Micotoxin; Polymorphonuclear leukocytes

Indexed keywords

GLIOTOXIN; METHYLPREDNISOLONE;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL FUNCTION; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL DEGRANULATION; CELLS, CULTURED; DENDRITIC CELLS; GLIOTOXIN; HUMANS; IMMUNOCOMPROMISED HOST; INFLAMMATION; METHYLPREDNISOLONE; MONOCYTES; NEUTROPHILS; PEROXIDASE; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; STEM CELL TRANSPLANTATION;

ASPERGILLUS FUMIGATUS;

EID: 34848812855     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0207090     Document Type: Article

References (46)

1. Baddley, J. W., Stroud, T. P., Salzman, D., Pappas, P. G. (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32, 1319-1324.
2. Denning, D. W. (1998) Invasive aspergillosis. Clin. Infect. Dis. 26, 781-803.
3. Denning, D. W., Anderson, M. J., Turner, G., Latge, J. P., Bennett, J. W. (2002) Sequencing the Aspergillus fumigatus genome. Lancet Infect. Dis. 2, 251-253.
4. Fukuda, T., Boeckh, M., Guthrie, K. A., Mattson, D. K., Owens, S., Wald, A., Sandmaier, B. M., Corey, L., Storb, R. F., Marr, K. A. (2004) Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol. Blood Marrow Transplant. 10, 494-503.
5. Latge, J. P. (1999) Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12, 310-350.
6. Balloy, V., Huerre, M., Latge, J. P., Chignard, M. (2005) Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect. Immun. 73, 494-503.
7. Grow, W. B., Moreb, J. S., Roque, D., Manion, K., Leather, H., Reddy, V., Khan, S. A., Finiewicz, K. J., Nguyen, H., Clancy, C. J., Mehta, P. S., Wingard, J. R. (2002) Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 29, 15-19.
8. Jantunen, E., Anttila, V. J., Ruutu, T. (2002) Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? Bone Marrow Transplant. 30, 925-929.
9. Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100, 4358-4366.
10. Ribaud, P., Chastang, C., Latge, J. P., Baffroy-Lafitte, L., Parquet, N., Devergie, A., Esperou, H., Selimi, F., Rocha, V., Derouin, F., Socié, G., Gluckman, E. (1999) Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin. Infect. Dis. 28, 322-330.
11. Kamei, K., Watanabe, A. (2005) Aspergillus mycotoxins and their effect on the host. Med. Mycol. 43 (Suppl. 1), S95-S99.
12. Waring, P., Beaver, J. (1996) Gliotoxin and related epipolythiodioxopiperazines. Gen. Pharmacol. 27, 1311-1316.
13. Grovel, O., Kerzaon, I., Petit, K., Robiou Du Pont, T., Pouchus, Y. F. (2006)Anew and rapid bioassay for the detection of gliotoxin and related epipolythiodioxopiperazines produced by fungi. J. Microbiol. Methods 66, 286-293.
14. Watanabe, A., Kamei, K., Sekine, T., Waku, M., Nishimura, K., Miyaji, M., Kuriyama, T. (2003) Immunosuppressive substances in Aspergillus fumigatus culture filtrate. J. Infect. Chemother. 9, 114-121.
15. Daly, P., Verhaegen, S., Clynes, M., Kavanagh, K. (1999) Culture filtrates of Aspergillus fumigatus induce different modes of cell death in human cancer cell lines. Mycopathologia 146, 67-74.
16. Kweon, Y. O., Paik, Y. H., Schnabl, B., Qian, T., Lemasters, J. J., Brenner, D. A. (2003) Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J. Hepatol. 39, 38-46.
17. Sutton, P., Beaver, J., Waring, P. (1995) Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels. Biochem. Pharmacol. 50, 2009-2014.
18. Eichner, R. D., Al Salami, M., Wood, P. R., Mullbacher, A. (1986) The effect of gliotoxin upon macrophage function. Int. J. Immunopharmacol. 8, 789-797.
19. Suen, Y. K., Fung, K. P., Lee, C. Y., Kong, S. K. (2001) Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization. Free Radic. Res. 35, 1-10.
20. Waring, P., Eichner, R. D., Mullbacher, A., Sjaarda, A. (1988) Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 263, 18493-18499.
21. Stanzani, M., Orciuolo, E., Lewis, R., Kontoyiannis, D. P., Martins, S. L., St John, L. S., Komanduri, K. V. (2005) Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 105, 2258-2265.
22. Kroll, M., Arenzana-Seisdedos, F., Bachelerie, F., Thomas, D., Friguet, B., Conconi, M. (1999) The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem. Biol. 6, 689-698.
23. Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T., Warring, P., Mühlbacher, A., Czernilofsky, A. P., Baeuerle, P. A. (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183, 1829-1840.
24. Upperman, J. S., Potoka, D. A., Zhang, X. R., Wong, K., Zamora, R., Ford, H. R. (2003) Mechanism of intestinal-derived fungal sepsis by gliotoxin, a fungal metabolite. J. Pediatr. Surg. 38, 966-970.
25. Yamada, A., Kataoka, T., Nagai, K. (2000) The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol. Lett. 71, 27-32.
26. Nishida, S., Yoshida, L. S., Shimoyama, T., Nunoi, H., Kobayashi, T., Tsunawaki, S. (2005) Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase. Infect. Immun. 73, 235-244.
27. Shah, D. T., Jackman, S., Engle, J., Larsen, B. (1998) Effect of gliotoxin on human polymorphonuclear neutrophils. Infect. Dis. Obstet. Gynecol. 6, 168-175.
28. Tsunawaki, S., Yoshida, L. S., Nishida, S., Kobayashi, T., Shimoyama, T. (2004) Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect. Immun. 72, 3373-3382.
29. Hebart, H., Bollinger, C., Fisch, P., Sarfati, J., Meisner, C., Baur, M., Loeffler, J., Monod, M., Latge, J. P., Einsele, H. (2002) Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 100, 4521-4528.
30. Abramson, J. S., Mills, E. L. (1988) Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev. Infect. Dis. 10, 326-341.
31. Carulli, G., Mattii, L., Azzara, A., Brizzi, S., Galimberti, S., Zucca, A., Benedetti, E., Petrini, M. (2006) Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor. Am. J. Hematol. 81, 318-323.
32. Wallace, P. J., Wersto, R. P., Packman, C. H., Lichtman, M. A. (1984) Chemotactic peptide-induced changes in neutrophil actin conformation. J. Cell Biol. 99, 1060-1065.
33. Koenig, J. M., Stegner, J. J., Schmeck, A. C., Saxonhouse, M. A., Kenigsberg, L. E. (2005) Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr. Res. 57, 424-429.
34. Lewis, R. E., Wiederhold, N. P., Chi, J., Han, X. Y., Komanduri, K. V., Kontoyiannis, D. P., Prince, R. A. (2005) Detection of gliotoxin in experimental and human aspergillosis. Infect. Immun. 73, 635-637.
35. Patterson, T. F., Boucher, H. W., Herbrecht, R., Denning, D. W., Lortholary, O., Ribaud, P., Rubin, R. H., Wingard, J. R., DePauw, B., Schlamm, H. T., Troke, P., Bennett, J. E., European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG), Pfizer Global Aspergillus Study Group (2005) Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin. Infect. Dis. 41, 1448 -1452.
36. Bok, J. W., Chung, D., Balajee, S. A., Marr, K. A., Andes, D., Nielsen, K. F., Frisvad, J. C., Kirby, K. A., Keller, N. P. (2006) GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence. Infect. Immun. 74, 6761-6768.
37. Comera, C., Andre, K., Laffitte, J., Collet, X., Galtier, P., Maridonneau-Parini, I. (2007) Gliotoxin from Aspergillus fumigatus affects phagocytosis and the organization of the actin cytoskeleton by distinct signaling pathways in human neutrophils. Microbes Infect. 9, 47-54.
38. Schneemann, M., Schaffner, A. (1999) Host defense mechanism in Aspergillus fumigatus infections. Contrib. Microbiol. 2, 57-68.
39. Roilides, E., Lyman, C. A., Panagopoulou, P., Chanock, S. (2003) Immunomodulation of invasive fungal infections. Infect. Dis. Clin. North Am. 17, 193-219.
40. Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L., Romani, L. (2004) TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173, 7406-7415.
41. Romani, L. (2004) Immunity to fungal infections. Nat. Rev. Immunol. 4, 1-23.
42. Marr, K. A. (2003) New approaches to invasive fungal infections. Curr. Opin. Hematol. 10, 445-450.
43. Beck, O., Topp, M. S., Koehl, U., Roilides, E., Simitsopoulou, M., Hanisch, M., Sarfati, J., Latge, J. P., Klingebiel, T., Einsele, H., Lehrnbecher, T. (2006) Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 107, 2562-2569.
44. Uhl, A., Czock, D., Boehm, B., Zellner, D., Mertz, A., Keller, F. (2002) Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fraction. J. Clin. Pharm. Ther. 27, 281-287.
45. Wehling, M. (1994) Novel aldosterone receptors: specificity conferring mechanism at the level of the cell membrane. Steroids 59, 160-163.
46. Bellocchio, S., Gaziano, R., Bozza, S., Rossi, G., Montagnoli, C., Perruccio, K., Calvitti, M., Pitzurra, L., Romani, L. (2005) Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signaling from TLR-2 to TLR-4. J. Antimicrob. Chemother. 55, 214-222.